Worldwide revenue from the global Eye Infections Treatment Market is estimated at USD 7.3 Billion for 2022, and the market is projected to progress at a CAGR of 3.8% from 2022 to 2030. Demand for eye infections treatment is anticipated to reach a worth of USD 9.9 Billion by the end of 2030.
| Attributes | Details |
|---|---|
| Eye Infections Treatment Market Size (2022) | USD 7.3 Billion |
| Predicted Revenue (2030) | USD 9.9 Billion |
| Forecasted Growth Rate (2022 to 2030) | 3.8% CAGR |
| Dominant Dosage Form | Eye Drops - 60.2% |
Eye infections treatment products account for 17.2% share of the global antibiotic market at present. OTC eye infection drops are expected to have a bright outlook over the decade.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 3.79% |
| H1, 2022 Projected | 3.84% |
| H1, 2022 Outlook | 3.74% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (-) 05 ↓ |
As per the FMI analysis, the H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 10 BPS. In H1-2022 when compared with H1-2021, the market growth rate of eye infections treatment is expected to fall by only 05 basis point share (BPS), as per FMI analysis.
The decline in the BPS values observed was attributed to the decrease in the cases of outpatient eye consultations, disruption in supply chain and distribution of ophthalmic eye drops, and the growing cases of infectious disease proliferation which was untended to during the lockdown period of the COVID-19 pandemic.
Conversely, rising pharmaceuticals production facilities in several economies such as India will splurge the growth output scenario of the overall market during the forecast period.
Key developments in the market include the development of intravitreal antibiotics. The market is highly influenced by regulatory impositions, disease epidemiology, and patient compliance, under the impact of macro and industry factors.
Eye infections have seen a substantial rise in incidence over the past years and this has led to an increase in eye infections treatment demand, and this trend is expected to be prevalent over the coming years as well. The global eye disease treatment market rose at a CAGR of 3.7% from 2015 to 2021.
Increasing instances of glaucoma, cataracts, diabetic retinopathy, and age-related macular degeneration (AMD) have resulted in high demand for eye infections treatment. Rising geriatric population is one of the major factors driving the eye infections treatment industry potential.
Increasing sedentary lifestyle trends, emergence of new allergies, rising adoption of contact lenses, rising need for pink eye treatment, and increasing rate of eye surgeries are some other factors that are driving demand for the treatment of eye infections.
Demand for eye infections treatment is anticipated to progress at a steady 3.8% CAGR from 2022 to 2030.
Principal Consultant
Market Driven by Rising Incidence of Multiple Vision Conditions across the World
Instances of eye infections are expected to see a rise on a global level, and this is expected to propel demand for medicines for eye infections. Eye drops for conjunctivitis, pink eye drops, stye eye drops, and keratitis eye drops are some prominent treatment options that are expected to see high demand over the forecast period. Eye infections treatment providers are launching new products to increase their market presence and boost revenues across the world.
Technical Advancements in Diagnosis & Treatment for Eye Infections to Fuel Market Potential
Constant research & development are evident in the healthcare industry and this is common for eye disease treatment and diagnosis as well. Post-operative ocular infections have been a major cause of concern as they account for a significant amount of total eye infections in the world.
Eye infections treatment providers are investing in the research and development of new diagnostic and treatment procedures to minimize the risks of infections in ocular surgeries. Increasing technological advancements are expected to influence the eye infections treatment market over the coming years.
Emerging Economies of India and China to Provide Lucrative Opportunities
The global eye infections treatment industry survey provides detailed analysis of the market across regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).
The eye infections treatment market in North America is expected to have a bright outlook over the forecast period, and most of the growth in this region is anticipated to be driven by the easy availability of eye treatments and high adoption of eye lenses.
The market for eye infections treatment in Europe is anticipated to be majorly governed by the increasing geriatric population in the region. Rising focus on healthcare infrastructure is also expected to crucially influence market potential over the coming years.
The market for eye infections treatment in regions such as East Asia and South Asia is anticipated to see significant demand from emerging economies such as India and China. High population density in these regions and developing healthcare infrastructure provide a lucrative setting for eye infections treatment product manufacturers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
USA Market Driven by High Incidence of Eye Infections and Increasing Need for Eye Surgeries
Advanced healthcare infrastructure provides a lucrative setting for eye infection treatments in the USA Increasing number of eye surgeries, rising usage of eye lenses, rising geriatric population, etc. are some factors that propel demand in the USA
Eye Infections Treatment Companies to Benefit from Developing Healthcare Infrastructure in India
India has seen a substantial increase in focus on eye infections treatment as instances of eye diseases in the nation has risen. Developing healthcare infrastructure provides eye infections treatment equipment suppliers an opportunity to discover the untapped market potential in India.
Increasing geriatric population, rising availability of eye infection medicines, increasing popularity of OTC eye drops, rising awareness about eye infections, etc. are major factors governing the eye infections treatment industry in India.
Antibiotic Eye Drops to See Hike in Demand through 2030
Eye drops have proven their effectiveness in the treatment of various eye diseases and eye infections and are a preferred treatment choice among patients as well. Stye eye drops, antiviral eye drops, antibiotic eye drops, pink eye drops, eye drops for conjunctivitis, and eye drops for blepharitis are some of the most used eye drops in the eye treatment industry.
OTC eye infection drops are expected to see an increase in demand. With a rise in instances of stye eye, pink eye, conjunctivitis, etc., demand for eye drops is expected to be a prominent trend over the forecast period as well.
Currently, the eye drops segment accounts for a mammoth share of 60.2% in the global eye infections treatment devices market, and is anticipated to maintain its dominance through 2030.
Eye infections treatment product suppliers are focusing on expanding their market presence across the world by initiating new product launches and boosting sales. Approval for new medications and treatments for eye infections is also expected to be a major trend over the coming years.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2030 |
| Historical Data Available for | 2015 to 2021 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia & Pacific; Middle East & Africa (MEA) |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, India, Indonesia, Malaysia, Singapore, Australia, New Zealand, Turkey, South Africa, and GCC Countries |
| Key Market Segments Covered | Drug Class, Dosage Form, Indication, Causative Agent, Distribution Channels, Region |
| Key Companies Profiled | Allergan plc; Alcon Laboratories Inc.; Bausch Health Companies Inc.; Pfizer Inc.; Akron Pharma Inc; Sanofi S.A.; GlaxoSmithKline plc; Intas Pharmaceuticals Ltd; Johnson & Johnson Services Inc.; Macleods Pharmaceuticals Ltd.; Merck & Co. Inc.; Mylan N.V.; Teva Pharmaceutical Industries Ltd. |
| Pricing | Available upon Request |
The global eye infections treatment market is projected to exhibit a CAGR of 3.8% from 2022 to 2030.
At present, eye drops account for a dominant market share of 60.2% in the global eye infections treatment industry.
Prime eye infections treatment product manufacturers are Allergan plc, Alcon Laboratories Inc., Bausch Health Companies Inc., Pfizer Inc., Akron Pharma Inc., Sanofi S.A., and GlaxoSmithKline plc.
Currently, the global eye infections treatment market is worth USD 7.3 Billion.
The eye infections treatment market is predicted to reach an estimated valuation of USD 9.9 Billion by 2030.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Market Background 5. Market Context 6. Global Eye Infection Treatment Market Demand (in Value or Size in USD Million) Analysis 2015 to 2021 and Forecast, 2022 to 2030 7. Global Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030, by Drug Class 7.1. Antibiotics 7.2. Antivirals 7.3. Antifungals 7.4. Antihistamines 7.5. Corticosteroids 7.6. Glucocorticoids 8. Global Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030, by Dosage Form 8.1. Tablet 8.2. Capsule 8.3. Ophthalmic Ointment 8.4. Eye Drops 8.5. Others 9. Global Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030, by Indication 9.1. Conjunctivitis 9.2. Keratitis 9.3. Endophthalmitis 9.4. Blepharitis 9.5. Stye or Sty (Hordeolum) 9.6. Uveitis 9.7. Cellulitis 9.8. Ocular Herpes 10. Global Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030, by Causative Agent 10.1. Virus 10.2. Bacteria 10.3. Fungus 10.4. Allergens 11. Global Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030, by Distribution Channel 11.1. Hospital Pharmacy 11.2. Retail Pharmacy 11.3. Drug Stores 11.4. Online Pharmacy 12. Global Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030, by Region 12.1. North America 12.2. Latin America 12.3. Europe 12.4. South Asia 12.5. East Asia 12.6. Oceania 12.7. Middle East and Africa (MEA) 13. North America Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030 14. Latin America Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030 15. Europe Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030 16. South Asia Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030 17. East Asia Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030 18. Oceania Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030 29. Middle East and Africa Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030 20. Emerging Countries Eye Infection Treatment Market Analysis 2015 to 2021 and Forecast 2022 to 2030 21. Market Structure Analysis 22. Competition Analysis 22.1. Allergan plc 22.2. Alcon Laboratories, Inc. 22.3. Bausch Health Companies Inc. 22.4. Pfizer Inc. 22.5. Akron Pharma Inc. 22.6. Sanofi S.A. 22.7. GlaxoSmithKline plc 22.8. Intas Pharmaceuticals Ltd 22.9. Johnson & Johnson Services, Inc. 22.10. Macleods Pharmaceuticals Ltd. 22.11. Merck & Co., Inc. 22.12. Mylan N.V. 22.13. Teva Pharmaceutical Industries Ltd. 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Eye Infections Treatment Market
